<SEC-DOCUMENT>0001562180-16-002651-index.html : 20160616
<SEC-HEADER>0001562180-16-002651.hdr.sgml : 20160616
<ACCEPTANCE-DATETIME>20160616160303
ACCESSION NUMBER:		0001562180-16-002651
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20160615
FILED AS OF DATE:		20160616
DATE AS OF CHANGE:		20160616

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tokai Pharmaceuticals Inc
		CENTRAL INDEX KEY:			0001404281
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		255 STATE STREET
		STREET 2:		6TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
		BUSINESS PHONE:		617-225-4348

	MAIL ADDRESS:	
		STREET 1:		255 STATE STREET
		STREET 2:		6TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Yanchik Joseph A., III
		CENTRAL INDEX KEY:			0001618154

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36620
		FILM NUMBER:		161717636

	MAIL ADDRESS:	
		STREET 1:		C/O AILERON THERAPEUTICS INC.
		STREET 2:		281 ALBANY STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primarydocument.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: primarydocument.html

Document 1 - RAW XML: primarydocument.xml

</DOCUMENT>
</SEC-DOCUMENT>